Evommune EVMN
NYSE EVMN
$8.26 -0.08 (-0.96%)
At close: Sep 30, 2026 · 4:00 PM EDT

Evommune (EVMN) Shares Outstanding (2024 - 2026)

Updated

Evommune's Shares Outstanding came in at 36.14 million for Q2 2026, compared with 1.54 million a year earlier and up 7.3% from the prior quarter.

Analysis

Evommune (EVMN) Shares Outstanding (2024 - 2026) Analysis & Trends

For FY2025, Evommune's Shares Outstanding was 6.14 million, up 306.9% from FY2024.

  • Going back by year, Shares Outstanding was 1.51 million in FY2024.
  • The Q2 2026 figure represents the highest quarterly Shares Outstanding in data going back to Q3 2024.
  • Business Quant data shows EVMN's Shares Outstanding at 33.67 million (Q1 2026), 6.14 million (Q4 2025) and 1.55 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.94 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.55 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.70 Mn
10 Evommune 299.69 Mn -337.83 Mn - 36.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 36.14 Mn
Mar 31, 2026 33.67 Mn
Dec 31, 2025 6.14 Mn
Sep 30, 2025 1.55 Mn
Jun 30, 2025 1.54 Mn
Mar 31, 2025 1.53 Mn
Dec 31, 2024 1.51 Mn
Sep 30, 2024 1.52 Mn
API Access

Evommune Shares Outstanding API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding&ticker=EVMN&period=max&api_key=YOUR_API_KEY